Clinicopathological and prognostic significance of programmed death ligand-1 expression in breast cancer: a meta-analysis
Programmed cell death-ligand 1 (PD-L1) may be a useful molecule for targeted immunotherapy. Therefore, this meta-analysis aimed to investigate PD-L1 expression in breast cancer and its associations with clinic...
BMC Cancer 2017 17:690
Published on: 17 October 2017